Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.

Podrobná bibliografie
Hlavní autoři: V. M. Alifirova, M. A. Titova, A. A. Vereschaka
Médium: Článek
Jazyk:English
Vydáno: Siberian State Medical University (Tomsk) 2010-08-01
Edice:Бюллетень сибирской медицины
Témata:
On-line přístup:https://bulletin.ssmu.ru/jour/article/view/1618

Podobné jednotky